...
首页> 外文期刊>Canadian journal of anesthesia: Journal canadien d'anesthesie >Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation: (La dexmedetomidine et une faible dose de ketamine assurent une sedation adequate pendant l'intubation fibroscopique vigile).
【24h】

Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation: (La dexmedetomidine et une faible dose de ketamine assurent une sedation adequate pendant l'intubation fibroscopique vigile).

机译:右美托咪定和小剂量氯胺酮为清醒的光纤插管提供足够的镇静作用:

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: We report the use of the alpha(2) agonist, dexmedetomidine, with low-dose ketamine as a safe and effective treatment strategy to provide adequate comfort and sedation for a patient who fulfilled criteria of a difficult airway and required awake fibreoptic intubation (AFOI). Clinical features: A 52-yr-old male with prostate cancer presented for radical prostatectomy. He reported several failed intubations with previous surgeries and airway examination was consistent with a difficult intubation. In addition, previous fibreoptic intubations were unsuccessful. The patient reported extreme apprehension concerning his airway management. The goal of medicating patients for AFOI includes providing comfort and sedation without causing a change in ventilatory status. Dexmedetomidine has a high affinity for the alpha(2) receptor and results in sedation without change in ventilatory status. In addition, dexmedetomidine is a potent anti-sialgogue which makes it desirable for cases involved with airway instrumentation. A loading dose of dexmedetomidine followed by a continuous infusion provided comfort and sedation within ten minutes. While bradycardia and hypotension have been reported with dexmedetomidine use, concurrent low-dose ketamine was employed in this case for it's cardiostimulatory properties and no bradycardia and hypotension were noted. The airway was anesthetized with selective nerve blocks and conditions for airway instrumentation were excellent. There was no change in oxygen saturation or ventilatory status during the administration of medications or airway manipulation. The patient was comfortable, sedated and tolerated the procedures well. There was no recall of the procedure. CONCLUSION: Dexmedetomidine and concurrent low-dose ketamine provided sedation and comfort to this patient who required an AFOI.
机译:目的:我们报告使用α(2)激动剂右美托咪定和小剂量氯胺酮作为一种安全有效的治疗策略,可为符合困难气道标准且需要清醒纤维插管的患者提供足够的舒适感和镇静作用( AFOI)。临床特征:一名52岁的男性前列腺癌患者接受了根治性前列腺切除术。他报告说,由于先前的手术几次插管失败,气道检查与插管困难相吻合。此外,以前的纤维插管术也没有成功。该患者报告对他的呼吸道管理极为担忧。为患者提供AFOI药物治疗的目标包括提供舒适性和镇静作用而不会导致通气状态改变。右美托咪定对α(2)受体具有很高的亲和力,可导致镇静作用,而不会改变通气状态。此外,右美托咪定是一种有效的抗唾液酸药,对于与气道器械有关的病例非常理想。右美托咪定的负荷剂量然后连续输注可在十分钟内提供舒适感和镇静作用。尽管已报道右美托咪定可导致心动过缓和低血压,但在这种情况下同时使用小剂量氯胺酮具有心脏刺激作用,因此未发现心动过缓和低血压。用选择性神经阻滞麻醉气道,并且气道仪器条件良好。在给药或气道操作期间,氧饱和度或通气状态没有变化。病人感到舒适,镇静并且耐受良好。没有撤回该程序。结论:右美托咪定和同时用小剂量氯胺酮为需要AFOI的患者提供镇静作用和舒适感。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号